Description du projet
Un coopération internationale pour renforcer le niveau de préparation aux pandémies
Les maladies infectieuses émergentes (MIE) compte parmi les risques les plus catastrophiques pour l’humanité. L’infrastructure de recherche européenne sur les agents hautement pathogènes (ERINHA) et ses partenaires proposent des collaborations avec les infrastructures de recherche des laboratoires à haut niveau de confinement (LHNC) dans le monde entier afin de renforcer les capacités de préparation et de réponse aux pandémies. Le projet INTERCEPTOR, financé par l’UE, entend faciliter l’accès aux LHNC, améliorer le capital humain,notamment la formation à la gestion des risques biologiques, faciliter le partage des ressources critiques et renforcer l’harmonisation et l’interopérabilité. INTERCEPTOR s’efforce d’établir un réseau mondial durable d’infrastructures de recherche à haut niveau de confinement en élargissant l’accès à ces installations et en promouvant le partage des connaissances, les programmes de formation et les échanges de personnel afin de renforcer la nouvelle génération de chercheurs et de gestionnaires d’installations LHNC.
Objectif
Emerging infectious diseases (EID) do not respect borders. They rank as global catastrophic risks for humanity, along with climate change and biodiversity loss. The COVID-19 pandemic showed how coordination of global research, through cooperation, and sharing of data and expertise, are crucial for efficient and effective preparedness to EIDs, and vital for a rapid response. Nevertheless, there are still major challenges limiting global cooperation among high containment laboratories (HCLs). HCLs are critical infrastructures for the development of medical countermeasures (e.g. vaccines and therapeutics) against high consequence pathogens. In order to fulfil its role, and given the global threat of EIDs, the European Research Infrastructure on Highly pathogenic Agents (ERINHA), together with its partners, proposes to establish and reinforce interactions with HCL research infrastructures (RI) worldwide, to strengthen pandemic preparedness and response capacities. INTERCEPTOR (INTERnational Cooperation of high containment research infrastructures: from Epidemic Preparedness TO Response), a consortium with key HCLs from Europe and across the world, will focus on access provision to HCLs, enhancement of the human capital of HCL, including in biorisk management, critical resources sharing, harmonisation and interoperability. The proposed actions will help ensure broader access to state-of-the-art HC facilities, while respecting the necessary biosecurity and biosafety constraints, and promote the establishment of a sustainable global network of HC RIs. By expanding access to HC RIs, strengthening the human capital base, promoting sharing of knowledge, skills and experience, and providing opportunities for common training programmes and staff exchanges, INTERCEPTOR will reinforce the next generation of HCL researchers and facility managers, and extend the opportunities for access to HCLs, required to push the boundaries of science and innovation in the field of EIDs.
Champ scientifique
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
- natural sciencesbiological sciencesecologyecosystems
- natural sciencesearth and related environmental sciencesatmospheric sciencesclimatologyclimatic changes
Mots‑clés
Programme(s)
Régime de financement
HORIZON-CSA - HORIZON Coordination and Support ActionsCoordinateur
1050 Bruxelles / Brussel
Belgique